Bloom Energy’s Capacity Pivot Puts a $54 Billion Bet on the Line

Bloom Energy shares surge 100% after record earnings and Oracle deal, but valuation debate rages as analysts diverge on capacity expansion risks.

The stock has doubled in a month, but the real question isn’t whether Bloom Energy can keep climbing — it’s whether the company can deliver on a manufacturing ramp-up that has no precedent in its industry.

Shares closed at $281.15 on April 30, after touching an intraday range of $261.53 to $297.94. The rally, which pushed the stock past the 100% gain mark in 30 days, was ignited by two catalysts: a blockbuster earnings report and a previously announced deal with Oracle for up to 2.8 gigawatts of Bloom’s fuel cell systems, tied to a $400 million warrant for the software giant to buy Bloom equity.

The first-quarter numbers were historic by any measure. Revenue doubled to $751 million, a 130% jump from the prior year, while adjusted earnings per share of $0.44 crushed analyst estimates by 255% — the largest positive surprise in the company’s recent history. Bloom swung to a profit from a loss in the year-ago period, with adjusted gross margin rising to 31.5% and adjusted EBITDA hitting $143 million. Product revenue led the charge, surging more than 200%.

Management wasted no time capitalizing on the momentum. The full-year 2026 revenue forecast was lifted to a range of $3.4 billion to $3.8 billion — the low end of the new guidance already exceeds the previous high end. At the midpoint, that implies roughly 80% growth year over year. Adjusted earnings per share are now expected to land between $1.85 and $2.25.

Analyst targets diverge as valuation debate intensifies

Wall Street responded with a flurry of price target upgrades, but the consensus masks deep disagreement. RBC Capital raised its target to $335 from $143 with an “Outperform” rating. Evercore ISI bumped its target to $295, Susquehanna to $293, and JPMorgan to $267. On the cautious side, Citi’s Vikram Bagri lifted his target to $281 but held a “Neutral” rating. Roth/MKM went to $225, also neutral, warning that the market is already pricing in extremely high order volumes and capacity expansions.

The spread is telling. Among 21 analysts covering the stock, the consensus leans bullish, but price targets range from $10 to $335 — an unusually wide gulf that reflects how little agreement exists on what Bloom is actually worth.

At current levels, the math is unforgiving. Even at the high end of the 2026 adjusted earnings guidance, the stock trades at a price-to-earnings ratio above 120. The price-to-sales multiple sits at roughly 20, and the trailing 12-month EBITDA multiple exceeds 130. Those figures leave no room for execution missteps.

The capacity challenge that defines the story

The operational crux of the next 18 months is straightforward: Bloom plans to double its annual manufacturing capacity from one gigawatt to two gigawatts by the end of 2026, at a cost of roughly $100 million. Management insists it will not fall short on either orders or production. New modular designs and higher automation are expected to slash installation times — a critical advantage for AI data center operators who need power online in months, not years.

But the scale of the ambition is what gives skeptics ammunition. The company’s current production run rate is around 200 megawatts annually. Getting to two gigawatts within a year would represent a tenfold increase — a feat with no parallel in the fuel cell industry. Management has said capacity is already growing by several hundred megawatts per quarter, but the gap between plan and proven output remains wide.

Hidden risks beneath the headline growth

Three concerns hang over the rally. First, the stock has been extraordinarily volatile, with sharp swings that suggest speculative positioning rather than steady accumulation. Second, insider selling has been significant, and dilution remains a risk given the Oracle warrant structure. Third, a curious disconnect emerged on the earnings call: management verbally described revenue growth of “more than 100%,” while the actual reported figure was 13.4% — a discrepancy that analysts are likely to probe in coming weeks.

There’s also the question of customer concentration. While Oracle has captured headlines, more than half of Bloom’s data center backlog comes from other hyperscalers, neocloud providers, and co-location operators. Still, nearly 50% of first-quarter revenue came from related parties — joint ventures in Korea and with Brookfield — though that’s down from almost 74% in the prior quarter, signaling a gradual shift toward independent customers.

A structural advantage that cuts both ways

Bloom’s core argument is compelling: North American grid interconnection queues now stretch five years or longer, while the company’s solid oxide fuel cells can be installed in months. For AI data centers demanding immediate power, that speed is a genuine competitive moat.

Yet the valuation already assumes near-flawless execution. The stock sits near its all-time high of $290.50, and with U.S. markets closed on May 1 for the holiday, investors have the weekend to digest a flood of analyst revisions and decide whether a company trading at more than 120 times earnings can justify the price tag — or whether the debate over what Bloom is really worth is only just beginning.